Top Markets
Coin of the day
Pear Therapeutics, Inc. Pear Therapeutics, Inc.

Pear Therapeutics, Inc.

PEAR
Rang in Aktien #40500
Pear Therapeutics, Inc. is a commercial-phase medical company focused on... Pear Therapeutics, Inc. is a commercial-phase medical company focused on inventing and distributing digital therapeutics. Its current offerings include reSET, which addresses substance use disorders involving alcohol, cannabis, cocaine, and stimulants; reSET-O, prescribed alongside buprenorphine for opioid use disorder; and Somryst, a digital solution for chronic insomnia. Beyond these marketed therapies, the company maintains a robust development pipeline of 14 prospective products. These investigational treatments span various therapeutic areas, encompassing psychiatry, neurology, and non-central nervous system conditions like gastrointestinal, oncological, and cardiovascular disorders. Founded in 2013, Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Aktienkurs
$0.0048
Zuletzt synchronisiert: 2023-05-23
Marktkapitalisierung
$132.48K
Veränderung (1 Tag)
-20.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel Pear Therapeutics, Inc. (PEAR)

Kategorie

Kursverlauf für Pear Therapeutics, Inc. (PEAR)
Höchster Schlusskurs: $0.01 am 2023-05-01

Niedrigster Schlusskurs: $6.62 am 2021-12-01
Kursverlauf der Aktie von Pear Therapeutics, Inc. von 2021 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2023 -99.56%
2022 -75.88%
2021 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$73.79 -2.05%
US
$129.57 -33.40%
AU
$60.41 169.79%
US
$54.93 -21.11%
US
$30.49 0.00%
US